Valuation: FDC Limited

Market Cap 52.29B 543M 475M 438M 404M 761M 778M 5.23B 2.06B 25.61B 2.04B 1.99B 88.17B P/E 2024
22.8x
P/E 2025 24.1x
Enterprise Value 47.15B 490M 428M 395M 364M 686M 701M 4.72B 1.86B 23.09B 1.84B 1.8B 79.49B EV / Sales 2024
3.32x
EV / Sales 2025 2.8x
Free-Float
30.05%
Yield 2024 *
-
Yield 2025 1.27%
1 day-0.38%
1 week-2.78%
Current month-0.88%
1 month+9.33%
3 months+18.07%
6 months+9.05%
Current year-0.71%
1 week 413.55
Extreme 413.55
435
1 month 380.2
Extreme 380.2
442
Current year 312.95
Extreme 312.95
442
1 year 312.95
Extreme 312.95
527.8
3 years 312.95
Extreme 312.95
658.85
5 years 225
Extreme 225
658.85
10 years 148.3
Extreme 148.3
658.85
Manager TitleAgeSince
Chief Executive Officer 90 19/11/2009
Chief Executive Officer 63 30/09/1993
Director of Finance/CFO - 24/10/2025
Director TitleAgeSince
Director/Board Member 63 30/09/1993
Director/Board Member 48 01/01/2002
Director/Board Member 84 16/11/2009
Change 5-day change 1-year change 3-year change Capi.($)
-0.38%-2.78% - - 713M
+0.83%-0.94%+54.61%+163.31% 1,043B
+1.08%-1.80%+54.84%+58.64% 602B
+0.85%+3.47%+34.11%+90.38% 449B
+0.78%-0.71%+30.04%+24.61% 327B
+1.41%+0.58%+33.92%+47.20% 279B
-0.27%-1.87%+22.13%+23.47% 264B
-1.87%+0.78%+22.79%+60.74% 201B
-0.80%+4.46%+24.65%+75.04% 169B
-0.18%+3.85%+2.12%-30.01% 143B
Average +0.09%-0.68%+31.02%+57.04% 386.34B
Weighted average by Cap. +0.51%-1.82%+40.11%+84.61%

Financials

2024 2025
Net sales 19.43B 202M 176M 163M 150M 283M 289M 1.94B 765M 9.52B 758M 741M 32.76B 21.08B 219M 191M 177M 163M 307M 313M 2.11B 830M 10.32B 822M 804M 35.54B
Net income 3.05B 31.69M 27.7M 25.56M 23.56M 44.4M 45.39M 305M 120M 1.49B 119M 116M 5.15B 2.67B 27.7M 24.21M 22.34M 20.59M 38.81M 39.67M 267M 105M 1.31B 104M 102M 4.5B
Net Debt -4.55B -47.24M -41.28M -38.09M -35.11M -66.18M -67.65M -455M -179M -2.23B -177M -174M -7.67B -5.15B -53.47M -46.73M -43.12M -39.75M -74.92M -76.58M -515M -203M -2.52B -201M -196M -8.68B
Logo FDC Limited
FDC Limited is an India-based company, which is principally engaged in the business of manufacturing and trading of pharmaceutical products. The Company is specialized in manufacturing Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies. Its products include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen Sodium, Miconazole Nitrate, Timolol Maleate, Amoxycillin + Clavulanic Acid, Rupatadine Fumarate, Salbutamol Sulphate, Kaolin Light/ Pectin, among others. The Company’s product offerings cover an extensive range of categories, including anti-infectives, gastrointestinal treatments, ophthalmic, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, respiratory care, gynecology, dermatology and analgesics. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
Employees
6,857
Date Price Change Volume
17/07/26 INR 420.10 -0.38% 86,854
16/07/26 INR 421.70 -0.57% 127,975
15/07/26 INR 424.10 +0.58% 52,937
14/07/26 INR 421.65 -1.48% 81,286
13/07/26 INR 428.00 -0.99% 108,030
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B